Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
7.4
4.1
Journals
Microorganisms
Special Issues
Human Infectious Diseases, Second Edition
share announcement

Human Infectious Diseases, Second Edition

A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Public Health Microbiology".

Deadline for manuscript submissions: 31 October 2025 | Viewed by 250

Special Issue Editor

Dr. Eleonora Cella

E-Mail Website
Guest Editor
Burnett School of Biomedical Sciences, University of Central Florida, Orlando, FL, USA
Interests: molecular epidemiology; genomic epidemiology; phylogenomics; microbiology; virology; phylogeny; bioinformatics; molecular microbiology; infectious diseases; public health
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

This Special Issue is the continuation of our previous Special Issue, entitled “Human Infectious Diseases”

The Special Issue offers a comprehensive exploration of the multifaceted landscape of infectious diseases, presenting a collection of articles that delve into the understanding, management, and prevention of a diverse array of infectious agents that impact global health.

This Special Issue encompasses a wide range of topics, including the epidemiology of infectious diseases, emerging and re-emerging pathogens, innovative diagnostic tools, treatment advancements, and the impact of infectious diseases on vulnerable populations. Furthermore, it addresses the intersection of infectious diseases with other public health challenges, such as antimicrobial resistance, vaccine hesitancy, and the influence of environmental factors.

Through the dissemination of cutting-edge research, clinical insights, and epidemiological perspectives, this Special Issue serves as a vital resource for healthcare professionals, researchers, and policymakers. It provides a platform for the exchange of knowledge and strategies aimed at combating existing infectious threats and preparing for future challenges in the realm of infectious diseases.

In conclusion, “Infectious Diseases” provides a holistic overview of the current state of infectious diseases globally, offering valuable insights that contribute to the ongoing efforts to understand, manage, and mitigate the impact of infectious agents, ultimately working towards the betterment of public health worldwide.

Dr. Eleonora Cella
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • human
  • infectious diseases
  • public health

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Review

15 pages, 720 KiB  
Review
Brevibacterium Species Infections in Humans—A Narrative Review
by Takis Panayiotou, Anastasia Vasilopoulou, Stella Baliou, Andreas G. Tsantes and Petros Ioannou
Microorganisms 2025, 13(5), 1097; https://doi.org/10.3390/microorganisms13051097 - 9 May 2025
Viewed by 206
Abstract
Brevibacterium species are Gram-positive, non-sporulating, coryneform, aerobic rods that are catalase positive and exhibit a distinctive transition from diptheroid to coccoid morphology during culture. Infections by these species are seldom identified. Objective: This narrative review aims to present all the reported cases of [...] Read more.
Brevibacterium species are Gram-positive, non-sporulating, coryneform, aerobic rods that are catalase positive and exhibit a distinctive transition from diptheroid to coccoid morphology during culture. Infections by these species are seldom identified. Objective: This narrative review aims to present all the reported cases of Brevibacterium spp. infections in humans, focusing on data about epidemiology, antimicrobial resistance, antimicrobial treatment, and mortality. A narrative review based on a literature search of PubMed/MedLine and Scopus databases was performed. In total, 41 studies providing data on 42 patients with Brevibacterium spp. infections were included in the present analysis. The median age was 48 years, while 57.5% were male. The presence of a central venous catheter and malignancy, and end-stage renal disease on peritoneal dialysis were the main predisposing factors. Bacteremia was the most common type of infection, with peritoneal dialysis-associated infections being the second most common. B. casei was the most commonly identified species. Microbial identification required the use of advanced molecular techniques, such as 16s rRNA sequencing or matrix-assisted laser desorption/ionization time of flight mass spectrometry in most cases. Brevibacterium spp. was highly resistant to the combination of trimethoprim with sulfamethoxazole, clindamycin, and common beta-lactams. The most commonly used antimicrobials were vancomycin and aminoglycosides. The mortality was about 10%. Clinicians and laboratory personnel should consider this pathogen in the differential diagnosis in patients with malignancy or peritoneal dialysis-associated peritonitis. Vancomycin should be used for empirical treatment and while antimicrobial susceptibility testing results are pending. Full article
(This article belongs to the Special Issue Human Infectious Diseases, Second Edition)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-1
Back to TopTop